Zymeworks Inc., a biotechnology company, announced its management will participate in three upcoming investor conferences: the Stifel Virtual Targeted Oncology Forum on May 20, the TD Cowen Oncology Innovation Summit on May 27, and the Jefferies Global Healthcare Conference on June 3. These events will feature one-on-one meetings and fireside chats, providing opportunities to discuss Zymeworks' pipeline of novel biotherapeutics and licensed healthcare assets. This participation highlights Zymeworks' ongoing efforts to engage investors and showcase its advancements in cancer and autoimmune disease treatments.
A study by i10X Research reveals significant bias in AI-driven job application evaluations, where identical resumes written by different AI models receive vastly different hire recommendations. The study analyzed 100 candidate profiles across four AI...
Adswerve has been selected as a North American partner for Google's new GCS Implementation Partner (GIP) program, part of the Data Strength Partner Program. This partnership helps brands improve first-party data infrastructure to recover lost convers...
In 2026, five small-cap stocks in the Russell 2000 index have each gained more than 400%, significantly outperforming major players like Micron and Dell, which rose about 260%. Four of these companies supply key components for AI infrastructure, incl...
SpaceX has increased its revolving credit facility from $1.5 billion to $5 billion, a 233% rise, just before its IPO. This move significantly enhances the company's financial flexibility, suggesting it is preparing for large investments in projects l...
Suntex Enterprises completed the acquisition of 100 acres in South Texas for approximately $2.5 million through its subsidiary Red Spur Land & Ranch Co. This land purchase marks the start of a multi-phase mixed-use development project including resid...
